Document is current
Any future updates will be listed below
-
Authors
Lindemann, Maike E. https://orcid.org/0000-0002-7761-775X
Jentzen, Walter
Küper, Alina
Costa, Pedro Fragoso
Gratz, Marcel
Umutlu, Lale
Nagarajah, James
Nekolla, Stephan G.
Rausch, Ivo
Herrmann, Ken
Quick, Harald H.
Kersting, David
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 23 February 2026
Accepted: 26 May 2026
First Online: 15 June 2026
Declarations
:
: All patient measurements were performed in accordance with the Declaration of Helsinki and the study was approved by the institutional ethics committee (University of Duisburg-Essen, medical faculty, Essen, ethics committee approval number: 11‐4822-4825-BO). All patients signed informed consent.
: All authors have no relevant conflict of interest to disclose with regard to this study. Alina T. Küper was supported by the Clinician Scientist Program of the University Medicine Essen Clinician Scientist Academy (UMEA; Faculty of Medicine and DFG), FU 356/12-2. David Kersting reports a research grant from Pfizer, personal fees from GE Healthcare and Novartis, travel grants from Life Molecular Imaging and Sanofi and speaker honoraria from Pfizer, outside the submitted work. Ken Hermann is an editor in the European Journal of Nuclear Medicine and Molecular Imaging .
